MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND GlobeNewswire November 24, 2025 MONDOVI, Wis., Nov. 24, 2025 (GLOBE NEWSWIRE) — Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.06 per share of common stock. The dividend will be payable on December 29, 2025 to stockholders of record […]

Toronto, Ontario–(Newsfile Corp. – November 24, 2025) – Highland Critical Minerals Corp. (CSE: HLND) (“Highland” or the “Company“) is pleased to announce that, together with its wholly owned subsidiary, 6025 Nunavut Ltd. (“6025 Nunavut“), on November 21, 2025, it executed a definitive asset purchase agreement (the “Agreement“) with an arm’s length individual (the “Vendor“) to

Toronto, Ontario–(Newsfile Corp. – November 24, 2025) – The Canadian Securities Exchange (“CSE” or “the Exchange”) today welcomed the listing of Bitzero Holdings Inc. (“Bitzero” or the “Company”). The Vancouver-based company’s common shares were listed for trading on the CSE today following Bitzero’s recent reverse takeover transaction. The ticker symbol is BITZ.U. Bitzero is a

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the closing of its previously announced underwritten public offering of 4,950,496 shares of Class A common stock at a price to the public of $101.00 per share. The offering closed on November

(NASDAQ:PRAX), BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into therapies for central nervous system (CNS) disorders driven by neuronal excitation-inhibition imbalance, today announced they will present the latest preclinical and clinical data and progress on trials across its precision epilepsy pipeline at

(NASDAQ:FORM), LIVERMORE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the following investor conference: UBS Global Technology Conference Location: The Phoenician HotelDate: December 2nd – 3rd, 2025Presentation Time: December 3rd: 2:55 pm – 3:25 pm MT About FormFactor: FormFactor, Inc. (NASDAQ: FORM), is a leading

(NasdaqGM:SYM), WILMINGTON, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, announced financial results for its fourth fiscal quarter and fiscal year 2025, which ended on September 27, 2025. Symbotic reported revenue of $618 million, a net loss of $19 million and adjusted

(NYSE:POAS), SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) — Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), an advanced microscopy solutions headquartered in Singapore, today announced the closing of the offering (the “Offering”) of 405,500 class A ordinary shares, par value US$0.0001 per share pursuant to Network 1 Financial Securities, Inc.'s (“Network

(NasdaqGM:HIFS), HINGHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ:HIFS) (“the Bank”), Hingham, Massachusetts, announced that its Board of Directors has declared a regular quarterly dividend of $0.63 per share. The dividend will be paid on January 14, 2026 to stockholders of record as of January 5, 2026. In addition to

Praxis to present latest preclinical and clinical advancements across leading epilepsy portfolio at the 2025 American Epilepsy Society (AES) Annual Meeting GlobeNewswire November 24, 2025 BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into therapies for central nervous system (CNS) disorders driven by